Publications by authors named "Sharon Merims"

Claim this Profile
I
Impact of COVID-19 on cutaneous squamous cell carcinoma severity in a tertiary referral center in Israel: Lessons for future pandemics.
Deborah Korn, Sivan Sheffer-Levi, Maayan Eitan-Wexler, Stephanie Ben-Shushan, Mordechai Avner, Sharon Merims

JAAD Int· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indurated Plaques in an Otherwise Healthy Child.
Edan Davidson, Sharon Merims, Rony Shreberk-Hassidim, Dan Harlev, Stephanie Benshushan

Pediatr Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventing skin toxicities induced by EGFR inhibitors by topically blocking drug-receptor interactions.
Nethanel Friedman, Liza Weinstein-Fudim, Yelena Mostinski, Jhonatan Elia, Sherri Cohen, Sharon Merims

Sci Transl Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of immune checkpoint receptors in the malignant phenotype of cutaneous T cell lymphoma.
Rony Shreberk-Hassidim, Anat Geiger-Maor, Galit Eisenberg, Sharon Merims, Emma Hajaj

Immunol Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Giant congenital melanocytic naevus with a novel CUX1-BRAF fusion mutation treated with trametinib.
Vered Molho-Pessach, Stav Hartshtark, Sharon Merims, Michal Lotem, Nadia Caplan

Br J Dermatol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermatological adverse events under programmed cell death-1 inhibitors as a prognostic marker in metastatic melanoma.
Rony Shreberk-Hassidim, Lilach Aizenbud, Shalev Lussheimer, Elena Thomaidou, Tali Bdolah-Abram, Sharon Merims

Dermatol Ther· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Skin Permeability Tests of Nanoparticles for Microscopy Imaging.
Nethanel Friedman, Sharon Merims, Jhonatan Elia, Ofra Benny

Bio Protoc· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pityriasis rubra pilaris induced by PD-1 inhibitor nivolumab.
Tal Goldberger, Gil Armoni, David Lavie, Sharon Merims, Alexander Maly

Int J Dermatol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical properties of gold nanoparticles affect skin penetration via hair follicles.
Nethanel Friedman, Arie Dagan, Jhonathan Elia, Sharon Merims, Ofra Benny

Nanomedicine· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector Functions.
Emma Hajaj, Elad Zisman, Shay Tzaban, Sharon Merims, Jonathan Cohen

Cancer Immunol Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint inhibitors: Better outcomes among advanced cutaneous head and neck melanoma patients.
Nir Hirshoren, Roni Yoeli, Jonathan E Cohen, Jeffrey M Weinberger, Nadia Kaplan, Sharon Merims

PLoS One· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous granuloma annulare mimicking dermatomyositis.
Karin Maoz, Shoshana Greenberger, Alexander Maly, Sharon Merims, Irit Tirosh

Pediatr Dermatol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint.
Emma Hajaj, Galit Eisenberg, Shiri Klein, Shoshana Frankenburg, Sharon Merims

Elife· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma-A Retrospective Study.
Reut Hadash-Bengad, Emma Hajaj, Shiri Klein, Sharon Merims, Stephen Frank

Front Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the potential of mucin 13 (MUC13) as a biomarker for carcinomas and other diseases.
Panagiota S Filippou, Annie H Ren, Dimitrios Korbakis, Lampros Dimitrakopoulos, Antoninus Soosaipillai, Sharon Merims

Clin Chem Lab Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Rapidly Expanding Ulcer in the Armpit of a 48-year-old Man: A Quiz.
Yael Renert-Yuval, Sharon Merims, Alexander Maly, Yuval Ramot

Acta Derm Venereol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble SLAMF6 Receptor Induces Strong CD8 T-cell Effector Function and Improves Anti-Melanoma Activity .
Galit Eisenberg, Roni Engelstein, Anat Geiger-Maor, Emma Hajaj, Sharon Merims

Cancer Immunol Res· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade.
Michal Lotem, Sharon Merims, Stephen Frank, Tamar Hamburger, Aviram Nissan

J Immunol Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive cell therapy: past, present and future.
Jonathan E Cohen, Sharon Merims, Stephen Frank, Roni Engelstein, Tamar Peretz

Immunotherapy· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Monitoring of Patients Treated With a Whole-Cell Melanoma Vaccine Engineered to Express 4-1BBL.
Roni Engelstein, Sharon Merims, Galit Eisenberg, Jonathan Cohen, Stephen Frank

J Immunother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Widespread morbilliform rash due to sorafenib or vemurafenib treatment for advanced cancer; experience of a tertiary dermato-oncology clinic.
Ayelet Ollech, Salomon M Stemmer, Sharon Merims, Michal Lotem, Aron Popovtzer

Int J Dermatol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human T cell crosstalk is induced by tumor membrane transfer.
Ronny Uzana, Galit Eisenberg, Sharon Merims, Shoshana Frankenburg, Aviad Pato

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Response to New Treatments and Prognosis in Melanoma Patients, by the Biomarker S-100β.
Vivian Barak, Vera Leibovici, Tamar Peretz, Ina Kalichman, Michal Lotem, Sharon Merims

Anticancer Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imprinting of lymphocytes with melanoma antigens acquired by trogocytosis facilitates identification of tumor-reactive T cells.
Galit Eisenberg, Ronny Uzana, Aviad Pato, Shoshana Frankenburg, Sharon Merims

J Immunol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Ctla-4 blockade: a new hope for the immunotherapy of malignant melanoma].
Michal Lotem, Sharon Merims, Steven Frank, Inna Ospovat, Tamar Peretz

Harefuah· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis